Pharmacy2U

Pharmacy2U Limited
Consolidated Financial Statements
For the Year
2017-18 to 2018-19

# Table of Contents
1 Income Statement
1.1 Income Statement - Summary View
1.2 Income Statement - Extended View
2 Balance Sheet
2.1 Balance Sheet - Compact View
2.2 Balance Sheet - Extended View
3 Cash Flow Statement
3.1 Cash Flow Statement - Compact View
3.2 Cash Flow Statement - Extended View
4 Additional Information
4.1 Disclosures - Remuneration &
Employee Information
4.2 Disclosures - Group Information
4.3 Disclosures - Related Party
Transaction
5 Auditor's Details

Notes:
The financials are prepared for "Pharmacy2U Limited" which is the primary legal entity for this company.
The company has filed financial statements till FY 2018-19.

Disclaimer:
The information present in the financial statements are computed periodically from sources believed to be reliable or
from available estimates collected using our best efforts. No warranties express or implied are made regarding the
completeness, correctness, suitability, legality and usefulness of any information in whole or in part.

Please read the footnotes for assumptions and inferences made.

 Pharmacy2U
Pharmacy2U Limited
Consolidated Income Statement
For the Fiscal Year
2017-18 to 2018-19
 Pharmacy2U
Income Statement - Summary View
GBP (Thousands)
Particulars
FY 2018-19 FY 2017-18

Revenue 60,672.00 43,168.00

Cost of Sales (45,509.00) (31,736.00)
Gross Profit/(Loss) 15,163.00 11,432.00
Administrative and Other expenses* (31,550.00) (23,907.00)
Profit/(Loss) before tax (16,387.00) (12,475.00)
Taxation 432.00 342.00
Profit/(Loss) for the year (15,955.00) (12,133.00)

Notes:
Fiscal Year(FY) for the company is from 1st Apr to 31st Mar
* includes other income, and expenses excluding Cost of Sales

Disclaimer:
The information present in the financial statements are computed periodically from sources believed to be reliable or from available estimates
collected using our best efforts. No warranties express or implied are made regarding the completeness, correctness, suitability, legality and
usefulness of any information in whole or in part.

Data sourced from Companies House, UK, under the Open Government Licence v3.0
 Pharmacy2U
Income Statement - Extended View
GBP (Thousands)
Particulars
FY 2018-19 FY 2017-18

Revenue 60,672.00 43,168.00

Cost of Sales (45,509.00) (31,736.00)
Gross Profit/(Loss) 15,163.00 11,432.00
Distribution costs (23,012.00) (16,832.00)
Administrative expenses - continuing (8,255.00) (6,002.00)
Administrative expenses - exceptional (219.00) (804.00)
Operating Profit/(Loss) (16,323.00) (12,206.00)
EBITDA (14,630.00) (10,167.00)
Amortisation (710.00) (551.00)
Depreciation (765.00) (684.00)
Exceptional items (218.00) (804.00)
Finance costs (64.00) (269.00)
Interest receivable 11.00 -
Bank interest payable (75.00) (269.00)
Profit/(Loss) before tax (16,387.00) (12,475.00)
Taxation 432.00 342.00
Uk corporation tax on losses for the year 432.00 342.00
Profit/(Loss) for the year (15,955.00) (12,133.00)

Notes:
Fiscal Year(FY) for the company is from 1st Apr to 31st Mar

Disclaimer:
The information present in the financial statements are computed periodically from sources believed to be reliable or from available estimates
collected using our best efforts. No warranties express or implied are made regarding the completeness, correctness, suitability, legality and
usefulness of any information in whole or in part.

Data sourced from Companies House, UK, under the Open Government Licence v3.0
 Pharmacy2U
Pharmacy2U Limited
Consolidated Balance Sheet
For the Fiscal Year
2017-18 to 2018-19
 Pharmacy2U
Balance Sheet - Compact View
GBP (Thousands)
Particulars
FY 2018-19 FY 2017-18

Net Assets 35,047.00 40,305.00

Non-current assets 9,272.00 8,166.00
Current assets 25,775.00 32,139.00
Equity and Liabilities 35,047.00 40,305.00
Current liabilities 17,495.00 16,551.00
Non-current liabilities 377.00 625.00
Equity 17,175.00 23,129.00

Notes:
Fiscal Year(FY) for the company is from 1st Apr to 31st Mar

Disclaimer:
The information present in the financial statements are computed periodically from sources believed to be reliable or from available estimates
collected using our best efforts. No warranties express or implied are made regarding the completeness, correctness, suitability, legality and
usefulness of any information in whole or in part.

Data sourced from Companies House, UK, under the Open Government Licence v3.0
 Pharmacy2U
Balance Sheet - Extended View
GBP (Thousands)
Particulars
FY 2018-19 FY 2017-18

Net Assets 35,047.00 40,305.00

Non-current assets 9,272.00 8,166.00
Intangible assets 4,755.00 4,764.00
Property, plant and equipment 3,901.00 2,785.00
Investments - 1.00
Deferred taxation 616.00 616.00
Current assets 25,775.00 32,139.00
Inventories 3,092.00 1,914.00
Goods for resale 3,092.00 1,914.00
Trade and other receivables 12,246.00 8,624.00
Trade receivables 8,217.00 5,665.00
Amounts due from parent undertaking 1,481.00 973.00
Other receivables 1,376.00 930.00
Prepayments and accrued income 1,172.00 1,056.00
Current taxation receivable 774.00 672.00
Cash and cash equivalents 9,663.00 20,929.00
Equity and Liabilities 35,047.00 40,305.00
Current liabilities 17,495.00 16,551.00
Trade and other payables 13,293.00 12,311.00
Trade payables 12,126.00 10,206.00
Other taxation and social security 187.00 356.00
Other payables 204.00 943.00
Accruals and deferred income 731.00 761.00
Deferred government grant 45.00 45.00
Borrowings 4,202.00 4,240.00
Receivables financing - -
Bank loan 202.00 240.00
Non-current liabilities 377.00 625.00
Trade and other payables 270.00 315.00
Borrowings 107.00 310.00
Bank loan 107.00 310.00
Equity 17,175.00 23,129.00
Called up share capital 10,001.00 28,034.00
Share premium account - 31,851.00

Notes:
Fiscal Year(FY) for the company is from 1st Apr to 31st Mar

Disclaimer:
The information present in the financial statements are computed periodically from sources believed to be reliable or from available estimates
collected using our best efforts. No warranties express or implied are made regarding the completeness, correctness, suitability, legality and
usefulness of any information in whole or in part.

Data sourced from Companies House, UK, under the Open Government Licence v3.0
 Pharmacy2U
Pharmacy2U Limited
Consolidated Cash Flow Statement
For the Year
2017-18 to 2018-19
 Pharmacy2U
Cash Flow Statement - Compact View
GBP (Thousands)
Particulars
FY 2018-19 FY 2017-18

Net cash from/(used in) operating activities (18,380.00) (11,400.00)

Net cash from/(used in) investing activities (2,582.00) (1,412.00)
Net cash from/(used in) financing activities 9,696.00 33,127.00
Net increase /(Decrease) in cash and cash equivalents (11,266.00) 20,315.00
Cash and cash equivalents at the beginning of the year 20,929.00 614.00
Cash and cash equivalents at the end of the year 9,663.00 20,929.00

Notes:
Fiscal Year(FY) for the company is from 1st Apr to 31st Mar

Disclaimer:
The information present in the financial statements are computed periodically from sources believed to be reliable or from available estimates
collected using our best efforts. No warranties express or implied are made regarding the completeness, correctness, suitability, legality and
usefulness of any information in whole or in part.

Data sourced from Companies House, UK, under the Open Government Licence v3.0
 Pharmacy2U
Cash Flow Statement - Extended View
GBP (Thousands)
Particulars
FY 2018-19 FY 2017-18

Cash flow from operating activities

Loss before tax (16,387.00) (12,475.00)
Depreciation 765.00 684.00
Amortisation 710.00 551.00
Increase in inventories (1,178.00) (960.00)
Increase in trade and other receivables (3,620.00) (4,094.00)
Increase in trade and other payables 936.00 4,536.00
Share based payments charge - 89.00
Interest paid 75.00 269.00
Interest received (11.00) -
Taxation recovered 330.00 -
Net cash from/(used in) operating activities (18,380.00) (11,400.00)
Cash flow from investing activities
Payments to acquire plant, property and equipment (1,881.00) (498.00)
Payments to acquire intangible assets (701.00) (914.00)
Cash acquired with subsidiary undertaking - -
Net cash from/(used in) investing activities (2,582.00) (1,412.00)
Cash flow from financing activities
Increase in borrowings - 4,000.00
Loan repayments (241.00) (3,106.00)
Share issue 10,001.00 32,502.00
Interest paid (75.00) (269.00)
Interest received 11.00 -
Net cash from/(used in) financing activities 9,696.00 33,127.00

Net increase /(Decrease) in cash and cash equivalents (11,266.00) 20,315.00

Cash and cash equivalents at the beginning of the year 20,929.00 614.00
Cash and cash equivalents at the end of the year 9,663.00 20,929.00

Notes:
Fiscal Year(FY) for the company is from 1st Apr to 31st Mar

Disclaimer:
The information present in the financial statements are computed periodically from sources believed to be reliable or from available estimates
collected using our best efforts. No warranties express or implied are made regarding the completeness, correctness, suitability, legality and
usefulness of any information in whole or in part.
 Pharmacy2U
Pharmacy2U Limited
Additional Information
For the Year
2017-18 to 2018-19
 Pharmacy2U
Remuneration & Employee Information

GBP (Thousands)
Directors' Remuneration FY 2018-19 FY 2017-18
Aggregate emoluments 449 625
Comapany contributions to money purchase pension schemes 9 9
Total 458 634

GBP (Thousands)
Staff costs FY 2018-19 FY 2017-18
Wages and salaries 9,375 6,921
Social security costs 665 506
Other pension costs 204 118
Share option expense - 89
Total 10,244 7,634

# of Employees and details ( including directors) - average FY 2018-19 FY 2017-18

Selling and distribution 225 154
Administration 74 64
Total 299 218

Disclaimer:
The information present in the financial statements are computed periodically from sources believed to be reliable or from available estimates collected
using our best efforts. No warranties express or implied are made regarding the completeness, correctness, suitability, legality and usefulness of any
information in whole or in part.

Data sourced from Companies House, UK, under the Open Government Licence v3.0
 Pharmacy2U
Group Information

Holding and Ultimate holding company

Name Nature of Relationship
P2U Holdings Limited Immediate and Ultimate Parent

Disclaimer:
The information present in the financial statements are computed periodically from sources believed to be reliable or from available
estimates collected using our best efforts. No warranties express or implied are made regarding the completeness, correctness,
suitability, legality and usefulness of any information in whole or in part.

Data sourced from Companies House, UK, under the Open Government Licence v3.0
 Pharmacy2U
Related Party Transaction

Disclosures - Related Party Transaction All numbers are in GBP (Thousands)

ChemD Holdings Limited LLPs
Categories of related parties FY 2018-19 FY 2017-18 FY 2018-19 FY 2017-18
Description of nature of related party relationship - -
Due amount 3,941,000 3,492,000 - -
Receivable amount - - 4,623 7,534

Disclaimer:
The information present in the financial statements are computed periodically from sources believed to be reliable or from available estimates collected
using our best efforts. No warranties express or implied are made regarding the completeness, correctness, suitability, legality and usefulness of any
information in whole or in part.

Data sourced from Companies House, UK, under the Open Government Licence v3.0
 Pharmacy2U
Pharmacy2U Limited
Auditors Details
For the Year
2017-18 to 2018-19
 Pharmacy2U
Auditor Details
Particulars FY 2018-19 FY 2017-18
Name of the Auditing Firm PricewaterhouseCoopers LLP PricewaterhouseCoopers LLP
Name of Auditor signing report Stephanie Yeates Stephanie Yeates
Designation Senior Statutory Auditor Senior Statutory Auditor
Central Square, 29 Wellington Street, Central Square, 29 Wellington Street,
Address Leeds - LS14DL Leeds - LS14DL

Disclaimer:
The information present in the financial statements are computed periodically from sources believed to be reliable or from available estimates
collected using our best efforts. No warranties express or implied are made regarding the completeness, correctness, suitability, legality and
usefulness of any information in whole or in part.

Data sourced from Companies House, UK, under the Open Government Licence v3.0
Any and all information either accessed from the website www.tracxn.com or having otherwise originated from Tracxn
Technologies Private Limited including but not limited to the information contained herein ("Data") is the sole property of
Tracxn Technologies Private Limited (hereinafter "Tracxn"). You shall not recirculate, distribute, transmit, publish, or sell the
Data or any portion thereof in any form or by any means, either for commercial or non-commercial use, or permit any third
party to use or distribute the Data or any portion thereof; to any other party, except with the prior written consent of Tracxn.
You may however incorporate insubstantial portions, extracts, abstracts or summaries from the Data into analysis,
presentations or tools for your customers or for your internal use, so long as Tracxn is clearly and visibly identified as the
source of information.

Further information please refer to our Terms of Use at www.tracxn.com

Copyright © 2020, Tracxn Technologies Private Limited. All rights reserved.